The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 58
Publisher
MDPI AG
Online
2017-05-30
DOI
10.3390/cancers9060058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Peng Han et al. Molecular Oncology
- Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway
- (2017) Feng Gao et al. ONCOLOGY REPORTS
- Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
- (2016) Zeynep Firtina Karagonlar et al. CANCER SCIENCE
- Targeting Signalling Pathways in Hepatocellular carcinoma
- (2016) Kaja Blagotinšek et al. CURRENT PHARMACEUTICAL DESIGN
- New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?
- (2016) Hyun Young Woo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Trends in the development of MET inhibitors for hepatocellular carcinoma
- (2016) Hitomi S Okuma et al. Future Oncology
- Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
- (2016) Eunice Yuen Ting Lau et al. Cell Reports
- MACC1 Suppresses Cell Apoptosis in Hepatocellular Carcinoma by Targeting the HGF/c-MET/AKT Pathway
- (2015) Yingmin Yao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- PKCε-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2
- (2015) Chi-Tan Hu et al. CELLULAR SIGNALLING
- Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma
- (2015) Zeynep F. Karagonlar et al. DRUG DEVELOPMENT RESEARCH
- Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer
- (2015) Makoto Nishio et al. INVESTIGATIONAL NEW DRUGS
- Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
- (2015) Y Gui et al. ONCOGENE
- The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
- (2015) Steven N. Steinway et al. PLoS One
- MET inhibitors for treatment of advanced hepatocellular carcinoma: A review
- (2015) Xing-Shun Qi WORLD JOURNAL OF GASTROENTEROLOGY
- Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression
- (2015) Jia-Ru Wu et al. Oncotarget
- The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo
- (2015) Marie Amitani Frontiers in Pharmacology
- Preclinical Trials for Prevention of Tumor Progression of Hepatocellular Carcinoma by LZ-8 Targeting c-Met Dependent and Independent Pathways
- (2015) Jia-Ru Wu et al. PLoS One
- A Pharmacodynamic/Pharmacokinetic Study of Ficlatuzumab in Patients with Advanced Solid Tumors and Liver Metastases
- (2014) J. Tabernero et al. CLINICAL CANCER RESEARCH
- Met endosomal signalling: In the right place, at the right time
- (2014) Rachel Barrow-McGee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance
- (2014) Christiane R. Maroun et al. PHARMACOLOGY & THERAPEUTICS
- A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
- (2013) A Santoro et al. BRITISH JOURNAL OF CANCER
- The role of endosomal signaling triggered by metastatic growth factors in tumor progression
- (2013) Chi-Tan Hu et al. CELLULAR SIGNALLING
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells
- (2013) Chung-Hsin Tsai et al. Evidence-based Complementary and Alternative Medicine
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- Met as a therapeutic target in HCC: Facts and hopes
- (2013) Silvia Giordano et al. JOURNAL OF HEPATOLOGY
- Lessons from (S)-6-(1-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an Inhibitor of Receptor Tyrosine Kinase c-Met with High Protein Kinase Selectivity but Broad Phosphodiesterase Family Inhibition Leading to Myocardial Degeneration in Rats
- (2013) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion
- (2013) Chang-Chang Jia et al. PLoS One
- Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells
- (2013) Mónica Díaz-Coránguez et al. PLoS One
- MET: A Critical Player in Tumorigenesis and Therapeutic Target
- (2013) C. R. Graveel et al. Cold Spring Harbor Perspectives in Biology
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
- (2012) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Pharmacokinetic drivers of toxicity for basic molecules: Strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor
- (2012) Dolores Diaz et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors
- (2011) J. Qi et al. CANCER RESEARCH
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
- (2011) Olorunseun O. Ogunwobi et al. CLINICAL & EXPERIMENTAL METASTASIS
- GGA3 Functions as a Switch to Promote Met Receptor Recycling, Essential for Sustained ERK and Cell Migration
- (2011) Christine Anna Parachoniak et al. DEVELOPMENTAL CELL
- miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway
- (2011) Sheng Tan et al. FEBS LETTERS
- c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
- (2011) Hanning You et al. HEPATOLOGY
- Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma
- (2011) Olorunseun O Ogunwobi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A direct role for Met endocytosis in tumorigenesis
- (2011) Carine Joffre et al. NATURE CELL BIOLOGY
- Molecular mechanism and physiological functions of clathrin-mediated endocytosis
- (2011) Harvey T. McMahon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma
- (2011) Jianjun Gao et al. PHARMACOLOGICAL RESEARCH
- Met Receptor: A Moving Target
- (2011) M. J. Clague Science Signaling
- Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- (2010) U. McDermott et al. CANCER RESEARCH
- MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors
- (2010) V. Cepero et al. CANCER RESEARCH
- Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis
- (2010) Nicholas O. Deakin et al. MOLECULAR BIOLOGY OF THE CELL
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA Interference
- (2009) Bin Xie et al. JOURNAL OF SURGICAL RESEARCH
- Endocytosis and signalling: intertwining molecular networks
- (2009) Alexander Sorkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HGF/MET Signaling in Ovarian Cancer
- (2008) Hong Zhou et al. CURRENT MOLECULAR MEDICINE
- Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
- (2008) Kunio Matsumoto et al. PROTEOMICS
- The biological role of HGF-MET axis in tumor growth and development of metastasis
- (2007) Ewa Lesko Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now